Studying Ways to Predict Flares in Rheumatoid Arthritis Patients
Studies blood markers and health records to predict flares in adults with rheumatoid arthritis.
Plain-language title generated from the registry record
Registry title: Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
Key facts
- Where
- Sohag, EgyptSee the site
Where in Egypt
- Rheumatology and Rehabilitation Department, Faculty of Medicine, Sohag UniversitySohag, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sohag University
- Trial code
- NCT07381296
- Record updated
- 19 May 2026
- Original description
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is:Read full original descriptionShow less
Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
The goal of this observational study is to help find better ways to predict when a flare of your disease (rheumatoid arthritis) might happen. By looking at your registered data, symptoms, disease characteristics, and specific markers in your blood, the investigators hope to help doctors make better decisions about your treatment in the future. The main question it aims to answer is:
Can specific patient data, disease characteristics, drug history, or markers in a patient's blood be used to predict when a rheumatoid arthritis flare is about to happen? Participants already diagnosed with rheumatoid arthritis and who have their disease controlled will be followed up every 3 months for any signs or symptoms of a flare.
Inclusion: Age: patients >18 years old; Patients with rheumatoid arthritis diagnosed according to the 2010 American College of Rheumatology (ACR)/European Alliance of Associations for Rheumatology Classification Criteria for RA; Clinical remission or low disease activity according to the disease activity score in 28 joints (DAS28).
Exclusion: Any autoimmune disease other than Rheumatoid arthritis. Severe infection, pregnancy, and malignancy; Age < 18 years.